Current approaches to fine mapping of antigen–antibody interactions
暂无分享,去创建一个
[1] T. T. Wu,et al. AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.
[2] A. Lesk,et al. Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.
[3] A. Gronenborn,et al. Complete resonance assignment for the polypeptide backbone of interleukin 1 beta using three-dimensional heteronuclear NMR spectroscopy. , 1990, Biochemistry.
[4] A. D. de Vos,et al. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface. , 1998, Structure.
[5] A. D. de Vos,et al. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. , 1999, Journal of molecular biology.
[6] Neil S. Greenspan,et al. Defining epitopes: It's not as easy as it seems , 1999, Nature Biotechnology.
[7] K. Strauch,et al. Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody. , 2001, Structure.
[8] A. Plückthun,et al. Directed in Vitro Evolution and Crystallographic Analysis of a Peptide-binding Single Chain Antibody Fragment (scFv) with Low Picomolar Affinity* , 2004, Journal of Biological Chemistry.
[9] Mathieu Rouard,et al. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. , 2005, Developmental and comparative immunology.
[10] G. Ligtvoet,et al. Structural aspects of antibody-antigen interaction revealed through small random peptide libraries , 1996, Molecular Diversity.
[11] J. M. Beals,et al. IL-1β Epitope Mapping Using Site-Directed Mutagenesis and Hydrogen−Deuterium Exchange Mass Spectrometry Analysis , 2005 .
[12] H. Kuwano,et al. Evaluation of tumor malignancy in esophageal squamous cell carcinoma using different characteristic factors. , 2005, Anticancer research.
[13] S. Englander. Hydrogen exchange and mass spectrometry: A historical perspective , 2006, Journal of the American Society for Mass Spectrometry.
[14] P. Parren,et al. The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD201 , 2006, The Journal of Immunology.
[15] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[16] R. Ladner. Mapping the Epitopes of Antibodies , 2007, Biotechnology & genetic engineering reviews.
[17] R. Meloen,et al. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS™ technology , 2007, Journal of molecular recognition : JMR.
[18] D. Nikolov,et al. Cell-cell signaling via Eph receptors and ephrins. , 2007, Current opinion in cell biology.
[19] Jesse D. Martinez,et al. Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients , 2007, Cancer biology & therapy.
[20] Yong-Sung Kim,et al. Comparative analyses of complex formation and binding sites between human tumor necrosis factor-alpha and its three antagonists elucidate their different neutralizing mechanisms. , 2007, Journal of molecular biology.
[21] Leonard A. Smith,et al. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. , 2007, Journal of molecular biology.
[22] Damon L. Meyer,et al. A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo. , 2008, Cancer research.
[23] Siyi Hu,et al. Epitope mapping and structural analysis of an anti‐ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism , 2008, Proteins.
[24] P. Orth,et al. Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody. , 2008, Journal of molecular biology.
[25] A. Poustka,et al. Combinatorial synthesis of peptide arrays with a laser printer. , 2008, Angewandte Chemie.
[26] U. Reineke. Antibody epitope mapping using de novo generated synthetic peptide libraries. , 2009, Methods in molecular biology.
[27] A. Böttger,et al. Epitope mapping using phage display peptide libraries. , 2009, Methods in molecular biology.
[28] S. Tuske,et al. Epitope mapping by amide hydrogen/deuterium exchange coupled with immobilization of antibody, on-line proteolysis, liquid chromatography and mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.
[29] J. Rucker,et al. Atomic-level mapping of antibody epitopes on a GPCR. , 2009, Journal of the American Chemical Society.
[30] Di Wu,et al. SEPPA: a computational server for spatial epitope prediction of protein antigens , 2009, Nucleic Acids Res..
[31] G. Gilliland,et al. Epitope mapping of anti-interleukin-13 neutralizing antibody CNTO607. , 2009, Journal of molecular biology.
[32] Lihua Huang,et al. Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling. , 2009, Biochemistry.
[33] S. Tuske,et al. Structure of IL-17A in complex with a potent, fully human neutralizing antibody. , 2009, Journal of molecular biology.
[34] Jianping Ding,et al. Structural Basis for the Blockage of IL-2 Signaling by Therapeutic Antibody Basiliximab , 2009, The Journal of Immunology.
[35] Michael Mahler,et al. Epitope specificity and significance in systemic autoimmune diseases , 2010, Annals of the New York Academy of Sciences.
[36] Jinquan Luo,et al. Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab. , 2010, Journal of molecular biology.
[37] Yasuo Yoshioka,et al. Solution of the Structure of the TNF-TNFR2 Complex , 2010, Science Signaling.
[38] P. Larsen,et al. Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity , 2010, The Journal of Biological Chemistry.
[39] Herren Wu,et al. Structural and functional characterization of an agonistic anti-human EphA2 monoclonal antibody. , 2011, Journal of molecular biology.
[40] John Corbin,et al. XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases , 2011, mAbs.
[41] Yanay Ofran,et al. Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure , 2012, Nucleic Acids Res..
[42] S. Tuske,et al. Mapping of discontinuous conformational epitopes by amide hydrogen/deuterium exchange mass spectrometry and computational docking , 2012, Journal of molecular recognition : JMR.
[43] P. Wilson,et al. Tools to therapeutically harness the human antibody response , 2012, Nature Reviews Immunology.
[44] J. Langedijk,et al. Structure-based design for high-hanging vaccine fruits. , 2012, Advances in immunology.
[45] Bjoern Peters,et al. The immune epitope database: a historical retrospective of the first decade , 2012, Immunology.
[46] R. Minter,et al. A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency , 2012, Cell Death and Differentiation.
[47] C. Bokemeyer,et al. Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab. , 2012, Neoplasia.
[48] D. Scott,et al. Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread , 2012, Virology Journal.
[49] Yanay Ofran,et al. Structural Consensus among Antibodies Defines the Antigen Binding Site , 2012, PLoS Comput. Biol..
[50] S. Meeks,et al. Epitope mapping of inhibitory antibodies targeting the C2 domain of coagulation factor VIII by hydrogen–deuterium exchange mass spectrometry , 2013, Journal of thrombosis and haemostasis : JTH.
[51] Xi Song,et al. Crystal structures of interleukin 17A and its complex with IL-17 receptor A , 2013, Nature Communications.
[52] Peng Zhou,et al. Epitope Mapping of Metuximab on CD147 Using Phage Display and Molecular Docking , 2013, Comput. Math. Methods Medicine.
[53] Ya-jun Guo,et al. Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View* , 2013, The Journal of Biological Chemistry.
[54] Mathias Hafner,et al. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β. , 2013, Journal of molecular biology.
[55] J. Voorberg,et al. Factor VIII C1 Domain Spikes 2092–2093 and 2158–2159 Comprise Regions That Modulate Cofactor Function and Cellular Uptake , 2013, The Journal of Biological Chemistry.
[56] M. Ultsch,et al. Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab. , 2013, Journal of molecular biology.
[57] Nicola Clementi,et al. Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools. , 2013, Drug discovery today.
[58] Ya-jun Guo,et al. Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor alpha-associated diseases from a molecular view , 2013 .
[59] R. Stevens,et al. Structure-function of the G protein-coupled receptor superfamily. , 2013, Annual review of pharmacology and toxicology.
[60] Z. Rao,et al. Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab* , 2013, The Journal of Biological Chemistry.
[61] J. Benschop,et al. Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα , 2013, Bioscience reports.
[62] L. Huerta,et al. HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: implications for the epitope structural features. , 2013, Molecular immunology.
[63] C. Lindsley. The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots. , 2013, ACS chemical neuroscience.
[64] Søren B. Padkjær,et al. Structural analysis of B-cell epitopes in antibody:protein complexes. , 2013, Molecular immunology.
[65] Guodong Chen,et al. Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications. , 2014, Drug discovery today.